Stock price when the opinion was issued
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Earnings beat estimates across the board. Covid related products unwinding lead to revenues falling 11%. Their acquisition has weighed on cash flow as well. It is currently consolidating and finding a base. Unlock Premium - Try 5i Free
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Good dividend yield. Able to pass inflation on to consumers. Revenue mix shifting towards healthcare. Demonstrated track record. Unlock Premium - Try 5i Free
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Attractive dividend yield. Able to pass inflation on to consumers. Revenue mix shifting towards healthcare. Demonstrated track record. Unlock Premium - Try 5i Free
(A Top Pick June 12/15. Up 66.05%.) Despite the stock being up, it is probably still no more expensive, from a valuation standpoint, than it was a year ago. Earnings have grown and the cash flow has grown significantly. Have made some acquisitions. Pays a nice dividend. Management owns a significant stake. Dividend yield of 4.4%.